Spravato Medicare spend in Pennsylvania
In 2024, 2 providers in Pennsylvania billed Medicare Part B $246,905 for esketamine administration across 264 sessions and 23 patients, ranking 12 of 19 states and making up 1.8% of national dollars.
Medicare paid
$247k
1.8% of national
Sessions billed
264
G2082 + G2083 services
Patients
23
11.5 sessions per patient
Providers billing
2
$123k per provider
Year over year
Medicare dollars billed in Pennsylvania by data year.
Providers billing in Pennsylvania
Ranked by Medicare dollars, 2024.
How to read this
How much does Medicare spend on Spravato in Pennsylvania?
The totals above cover Medicare Part B fee-for-service payments for esketamine administration billed by providers with a Pennsylvania practice address, aggregated by rendering NPI.
Which providers bill it?
Every Pennsylvania rendering NPI in the CMS file is listed, ranked by dollars, with a link to that provider's own page.
What is missing?
Medicare Advantage, Medicaid and commercial payers are not in the file, and CMS suppresses provider-code combinations with fewer than eleven patients. Treat these figures as a floor, not the full market.
Where does the data come from?
CMS Medicare Physician & Other Practitioners — by Provider and Service, HCPCS G2082 and G2083, data year 2024.
Page: /spravato-market-dashboard/pennsylvania. Source: CMS public use file, 2024.
Build the list for one county and see whether the names are right.
Ask in plain language. RepVector finds the universe, enriches each target from its own website, scores it 0–100, and hands you a ranked call list with phones, addresses and named contacts.
3 free runs — no card required.